mRNA therapy restores ureagenesis and corrects glutathione metabolism in argininosuccinic aciduria
Gurung, S.; Timmermand, O. V.; Perocheau, D.; Gil-Martinez, A. L.; Minnion, M.; Touramanidou, L.; Fang, S.; Messina, M.; Khalil, Y.; Barber, A. R.; Edwards, R. S.; Finn, P. F.; Cavedon, A.; Siddiqui, S.; Rice, L.; Martini, P. G. V.; Mills, P. B.; Waddington, S. N.; Gissen, P.; Eaton, S.; Ryten, M.; Feelisch, M.; Frassetto, A.; Witney, T. H.; Baruteau, J.
Show abstract
Argininosuccinate lyase (ASL) is a key enzyme integral to the hepatic urea cycle which is required for ammonia detoxification, and the citrulline-nitric oxide (NO) cycle for NO production. ASL deficient patients present with argininosuccinic aciduria (ASA), an inherited metabolic disease with hyperammonaemia and a chronic systemic phenotype with neurocognitive impairment and chronic liver disease. ASL deficiency as an inherited model of systemic NO deficiency, shows enhanced nitrosative and oxidative stress. Here, we describe the dysregulation of glutathione biosynthesis and upstream cysteine utilization in ASL-deficient patients and mice using targeted metabolomics and in vivo positron emission tomography (PET) imaging using (S)-4-(3-18F-fluoropropyl)-L-glutamate ([18F]FSPG). Upregulation of cysteine metabolism contrasted with glutathione depletion and down-regulated antioxidant pathways. hASL mRNA encapsulated in lipid nanoparticles corrected and rescued the neonatal and adult Asl-deficient mouse phenotypes, respectively, enhancing ureagenesis and glutathione metabolism and ameliorating chronic liver disease. We further present [18F]FSPG PET as a novel non-invasive diagnostic tool to assess liver disease and therapeutic efficacy in ASA. These findings support clinical translation of mRNA therapy for ASA.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Off-target depletion of plasma tryptophan by allosteric inhibitors of BCKDK 95%
- The Diabetes Gene Tcf7l2 Organizes Gene Expression in the Liver and Regulates Amino Acid Metabolism 95%
- Loss of Carnitine Palmitoyltransferase 1a Reduces Docosahexaenoic Acid-Containing Phospholipids and Drives Sexually Dimorphic Liver Disease in Mice 94%
Similar papers in this journal
- Transfer of hepatocellular microRNA regulates cytochrome P450 2E1 in renal tubular cells 93%
- Impaired mitochondrial ketone body oxidation in insulin resistant states 93%
- Survey of extracellular communication of systemic and organ-specific inflammatory responses through cell free messenger RNA profiling in mice 92%
Similar papers in this journal
- Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis 95%
- Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females. 95%
- Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis 95%
Similar papers in this journal
- Mitochondrial complex III deficiency drives c-MYC overexpression and illicit cell cycle entry leading to senescence and segmental progeria 94%
- NAD+ repletion with niacin counteracts cancer cachexia 94%
- Lysosomal cystine export regulates mTORC1 signaling to guide kidney epithelial cell fate specialization 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.